[Development of hormone assay methods]

Area of Science:

• Endocrinology and Immunology
• Biochemical Assays
• Analytical Chemistry

Context:

• Traditional bioassays and chemical methods for hormone measurement lacked sensitivity, requiring large sample volumes.
• Radioimmunoassay (RIA), introduced in 1959, significantly improved hormone determination sensitivity, enabling measurement of various peptide and non-peptide hormones.
• The development of monoclonal antibodies and two-site immunoradiometric assays further enhanced sensitivity and specificity.

Purpose:

• To review the evolution of hormone assay methodologies, from traditional methods to advanced immunoassays.
• To highlight the advantages and limitations of radioimmunoassays (RIA) and their non-isotopic alternatives.
• To discuss the role of various techniques, including radioreceptor assays and in vitro bioassays, in modern hormone analysis.

Summary:

• Early hormone measurements relied on low-sensitivity bioassays. Radioimmunoassay (RIA) emerged as a sensitive technique for various hormones.
• Two-site immunoradiometric assays and monoclonal antibodies improved RIA performance.
• Non-isotopic immunoassays (chemiluminescence, fluorescence, enzyme-based) now offer comparable sensitivity to RIA.
• Alternative methods like radioreceptor assays and in vitro bioassays provide complementary approaches to hormone measurement.

Impact:

• The shift towards sensitive immunoassays has transformed hormone quantification in clinical diagnostics and research.
• Non-isotopic immunoassays offer safer and potentially more cost-effective alternatives to RIA.
• The availability of diverse, sensitive hormone assay methods allows for more accurate diagnosis and monitoring of endocrine disorders.